Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Adaptimmune Therapeutics PLC ADR buy BiotechBee

Adaptimmune Therapeutics PLC ADR
Start price
€0.98
04.02.24 / 60%
Target price
€1.50
31.10.25
Performance (%)
14.29%
End price
€1.12
29.04.24
Summary
This prediction ended on 29.04.24 with a price of €1.12. The prediction had a final performance of 14.29%. BiotechBee has a follow-up prediction for Adaptimmune Therapeutics PLC ADR where he still thinks Adaptimmune Therapeutics PLC ADR is a Buy. BiotechBee has 60% into this prediction
Performance without dividends (%)
Name 1w 1m
Adaptimmune Therapeutics PLC ADR -2.804% -2.804%
iShares Core DAX® 0.476% -0.039%
iShares Nasdaq 100 1.290% 0.504%
iShares Nikkei 225® 1.300% -2.135%
iShares S&P 500 0.829% 0.193%

According to BiotechBee what are the pros and cons of Adaptimmune Therapeutics PLC ADR for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Adaptimmune Therapeutics PLC ADR diskutieren
Prediction Buy
Perf. (%) 14.29%
Target price 1.500
Change
Ends at 31.10.25

Buy mit Kursziel 1,5

BiotechBee 
0
Report Share
04.02.24
In the thread Trading Adaptimmune Therapeutics PLC ADR
Prediction Buy
Perf. (%) 14.29%
Target price 1.500
Change
Ends at 31.10.25

Buy beendet

BiotechBee 
0
Report Share
29.04.24

Current prediction by BiotechBee for Adaptimmune Therapeutics PLC ADR

buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.12
29.04.24
€1.70
31.07.26
-7.14%
06.05.24

Could be very worthwhile Investment >20% year
BiotechBee 
29.04.24 50%